Vimarsana
Biggest News Aggregation in the World

Ankind Ipo Subscription News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ankind Ipo Subscription. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ankind Ipo Subscription Today - Breaking & Trending Today

Mankind Pharma shares extend gain after solid listing; should you stay put or book profits? - Vimarsana News

Mankind Pharma shares extend gain after solid listing; should you stay put or book profits?

The bullish momentum in Mankind Pharma continued even after listing as the stock advanced another 9 per cent to Rs 1,414, extending the overall gains to about 31 per cent.

Mankind Pharma share bumper listing: Stock debuts at 20% premium; what should investors do? - Vimarsana News

Mankind Pharma share bumper listing: Stock debuts at 20% premium; what should investors do?

Mankind Pharma share price: Mankind Pharma shares debuted at a 20% premium on Dalal Street today. The stock of India’s fourth largest pharmaceutical company got listed at Rs 1,300 on BSE and NSE, against the issue price of Rs 1,080. Watch this Visual Story to know what investors should do with the stock.

Mankind Pharma shares make solid market debut, list at 20% premium over issue price - Vimarsana News

Mankind Pharma shares make solid market debut, list at 20% premium over issue price

The IPO of Mankind Pharma was open for subscription between April 25-27 in the price range of Rs 1,026-1,080 per share as the company raised 4,326 crore and issue was overall booked 15.32 times.

Mankind Pharma IPO GMP: Here what grey market signals ahead of listing? - Vimarsana News

Mankind Pharma IPO GMP: Here what grey market signals ahead of listing?

The IPO of Mankind Pharma, India’s fourth largest pharmaceutical company, received a strong response from the investors and was overall subscribed 15.32 times.

Mankind Pharma IPO: Check share allotment status & latest grey market premium - Vimarsana News

Mankind Pharma IPO: Check share allotment status & latest grey market premium

The IPO of Mankind Pharma was overall subscribed 15.32 times. The issue was open for subscription between April 25-27 in the price range of Rs 1,026-1,080 per share.